2025 ACMG Journals Manuscript Reviewer CE
Available for PhD, Genetic Counselor and Other Healthcare Professionals.
Description

 

 

Date of Release: January 7, 2025
Expiration Date: December 31, 2025
Credits offered: 15 CME
Estimate time of completion: 3 hours per review and up to 15 credits per calendar year.
Course must be completed by the expiration date

ACMG Journals (Genetics in Medicine  and Genetics in Medicine Open) 
Manuscript Reviewer CE Guidelines

Thank you for agreeing to provide a review for Genetics in Medicine (GIM) and Genetics in Medicine Open (GIMO). We owe the success of the journal to our reviewers ‐ clinicians, scientists, and scholars who take time out of their busy schedules to carefully read and critique manuscripts contributing to the integrity and quality of scholarly publications. Please refer to ACMG Journals guidelines and policies below on eligibility to receive CE credit for peer review of a manuscript under consideration with the journal.

Target Audience
Genetics in Medicine and Genetics in Medicine Open reviewers

Learning Objectives
Participating in the review process may lead the reviewer to identify gaps in knowledge of their field, learn new skills, or reinforce existing expertise in their practice in order to complete the review process effectively.

At the conclusion of a review, participants should be able to:

1.    Analyze the manuscript and understand and communicate its strengths and weaknesses
2.    Summarize the quality and applicability of the manuscript to the field of medical genetics and genomics
3.    Describe the impact of the manuscript on their own practice and/or research

Accredited Continuing Education Information

Continuing Medical Education
AMA PRA Category 1TM and CME AMA & CME Other


Accreditation

The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Desgnation (3 hours per review and up to 15 credits per calendar year)
The American College of Medical Genetics and Genomics designates this manuscript review activity for a maximum of 15 AMA PRA Category 1 Credits™ per year. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Non-physicians may request a certificate of attendance for their participation.

Claiming your Educational Credits

When submitting your review to GIM Open, click “YES” if you would like to receive CME/CE credit for your review. You will be awarded CME/CE credit if your review meets the following requirements:

 

1.    Submitted in a timely manner
2.    Identifies the strengths and weaknesses of the manuscript
3.    Communicates review feedback effectively to the editors
4.    You will receive an invitation code to enroll in the course from the editorial staff. 
5.    After successful enrollment you may complete the self-report form, respond to self-assessment questions, and claim credits.

Learner Data Consent

ACMG Education reports learner data to respective agency boards and you will be asked for consent during the evaluation process. Your compliance with deadlines and completing evaluations are part of the process in meeting learner needs and ACMG’s education mission.

Financial Disclosures

GIM follows the COPE Ethical Guidelines for Peer Reviewers. To maintain the integrity of peer review, reviewers should not review a manuscript for the journal if they do not think that they are competent to assess the research described, they believe there is a conflict of interest that might bias their assessment of the manuscript, or there is any other situation that could bias their review. Reviewers should refer to GIM’s policy on potential conflicts prior to agreeing to act as a reviewer for the journal.

Accredited Continuing Education Financial Disclosure
The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.

ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.
*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Journal Editor Mitigation Policy
ACMG adheres to ACCME Standards by clearly defining the roles and responsibilities of all participants in its activities. For non-clinical activities, ACMG is not required to identify, mitigate, or disclose relevant financial relationships. Editors involved in such activities are restricted to administrative functions, such as monitoring the progress of reviewers. They have no role in the development, selection, or review of educational content, ensuring that these tasks remain free from potential conflicts of interest.


ACMG Education Policies
Please review the policies below regarding the ACMG Education program
Financial Disclosures and Mitigation Procedure 
ACMG Content Validation Policy
ACMG Content Branding Policy


All of the relevant financial relationships listed for these individuals have been mitigated.
 

Participant Name Role: Co-Chair/ CE Presenter / Moderator / Peer Reviewer Financial Disclosure for 24 Months (relationship is ongoing)
Adeyemo, Adebowale GIM Open Editor Pending
AlKuraya, Fowzan GIM Editor SAB: Neutrolis, Inc.
Employee: Lifera Omerics
Bennet, Robin GIM Editor No Relevant Financial Relationship
Bombard, Yvonne GIM Open Editor Pending
Brunetti-Pierri, Nicola GIM Open Editor No Relevant Financial Relationship
Choy, Richard GIM Open Editor Pending
Couser, Natario GIM Open Editor No Relevant Financial Relationship
Cox, Allison GIM Editor No Relevant Financial Relationship
Dhar, Shweta GIM Editor No Relevant Financial Relationship
Drexler, Diane Dunham GIM Editor No Relevant Financial Relationship
Duque-Lasio, Maria Laura GIM Editor No Relevant Financial Relationship
Freeman, Peter GIM Open Editor No Relevant Financial Relationship
Freeman, Peter GIM Editor No Relevant Financial Relationship
Gambello, Michael GIM Editor No Relevant Financial Relationship
Goddard, Katrina GIM Editor No Relevant Financial Relationship
Hisama, Fuki GIM Open Editor DSMB: Larimar Therapeutics
Koeberl, Dwight GIM Editor Consultant: AskBio, Bayer Pharmaceuticals 
DSB: Baxalta, Takeda Pharmaceuticals 
Patent: Bayer Pharmaceuticals
Kozel, Beth GIM Editor No Relevant Financial Relationship
Lazaro-Munoz, Gabriel GIM Editor No Relevant Financial Relationship
Lansdon, Lisa GIM Editor No Relevant Financial Relationship
Lebo, Matthew GIM Open Editor No Relevant Financial Relationship
Levy-Lahad, Ephrat GIM Editor No Relevant Financial Relationship
Li, Hong GIM Open Editor pending
Li, Marilyn GIM Open Editor No Relevant Financial Relationship
Lu, Qiongshi GIM Open Editor No Relevant Financial Relationship
Miller, David GIM Editor Stock: Vertex Pharmaceuticals Inc.
Mori, Mari GIM Editor No Relevant Financial Relationship
Mvundura, Mercy GIM Editor No Relevant Financial Relationship
Nathanson, Kate GIM Editor No Relevant Financial Relationship
Ormond, Kelly GIM Open Editor No Relevant Financial Relationship
Pereira, Stacey GIM Editor No Relevant Financial Relationship
Porath, Binu GIM Editor Employee: Labcorp
Rahm, Alanna GIM Editor pending
Rasmussen, Sonja GIM Editor pending
Rehder, Catherine GIM Editor Consultant: Alexion Pharmaceuticals, Amicus Therapeutics, Inc.
Riggs, Erin GIM Open Editor Consultant: Illumina, Inc., Mirum Pharmaceuticals
Rose, Nancy GIM Editor Consultant: BillionToOne, Inc.
Schrodi, Steve GIM Editor Patents: Celera Corporation
Scott, Stuart GIM Open Editor No Relevant Financial Relationship
Shankar, Suma GIM Editor No Relevant Financial Relationship
Smith, Hadley GIM Editor Consultant: Illumina, Inc.
Steiner, Robert GIM Editor Consultant: Mirum Pharma; PTC Therapeutics; Ultragenyx Pharmaceuticals
Employee: PreventionGenetics, subsidiary of Exact Sciences
Patents: in newborn screening
Stevenson, Dave GIM Editor Consultant: BioMarin; Novartis
Stewart, Douglas GIM Editor No Relevant Financial Relationship
Sutton, V.Reid GIM Editor Stock: Aceragen
Speaker’s Bureau: Abbott Nutrition 
Consultant: Applied Therapeutics; Biomarin Pharmaceuticals; QED Therapeutics 
Grant: Ultragenyx Pharmaceutical, Inc.
Tan, Wen-Hann GIM Open Editor Consultant: Baker Co.; Coactuate: Denali Therapeutics Inc.
Research: F. Hoffman LaRoche Ltd.; Ionis Pharmaceuticals; Ultragenyx Pharmaceuticals 
Tarczy-Hornoch, Peter GIM Editor No Relevant Financial Relationship
Webb, Bryn GIM Editor No Relevant Financial Relationship
Wu, Ryanne GIM Editor Employee: 23andMe 
Consultant: MeTree&You
Wu, Nan GIM Open Editor Grant: Illumina
Yin, Xianyong GIM Editor No Relevant Financial Relationship
Yuan, Bo GIM Open Editor Itellectual Property: UptoDate

 

Disclaimer: ACMG educational programs are designed primarily as an educational tool for healthcare professionals who wish to increase their understanding of the application of genomic technologies to patient care. The ACMG does not endorse, or recommend the use of this educational program to make patient diagnoses, particular by individuals not trained in medical genetics. Adherence to the information provided in these programs does not necessarily ensure a successful diagnostic outcome. The program should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed at obtaining the same results. In determining the propriety of any specific procedure or test, a healthcare professional should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen.

Questions regarding CE credit should be directed to education@acmg.net

Summary
Availability:
Self-Report
Expires on Dec 31, 2025
Cost:
FREE
Credit Offered:
Self-Report

© 2025 American College of Medical Genetics and Genomics. All rights reserved.

Powered By